Coronavirus Disease 2019 (COVID-19): A Brief Report

Coronavirus Disease 2019 (COVID-19): A Brief Report

Authors

  • Domenico Lorenzo Urso Emergency Department - Spoke Hospital Corigliano-Rossano (CS), Italy

DOI:

https://doi.org/10.7175/cmi.v14i1.1467

Keywords:

SARS-CoV-2, Coronavirus, Pandemic, Pneumonia, Respiratory Support

Abstract

Severe acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak.

Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough. Bilateral lung involvement with ground-glass opacities (GGOs) is the most common finding from computed tomography (CT) images of the chest.

At present, there are no specific antiviral drugs against SARS-CoV-2 infection for potential therapy of humans. Current treatments are mainly focused on symptomatic and respiratory support in patients with COVID-19. Preventive measures are the current strategy to limit the spread of cases.

The present report summarizes the point of the situation about this global emergency.

References

Lu H, Stratton CW, Tang YW, et al. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol 2020; 92: 401-2; https://doi.org/10.1002/jmv.25678

Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382: 727-33; https://doi.org/10.1056/NEJMoa2001017

World Health Organization, WHO Director-General’s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020. (2020). Available at https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (last accessed April 2020)

Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol (2020); 5: 536-44; https://doi.org/10.1038/s41564-020-0695-z

Delamater PL, Street EJ, Leslie TF, et al. Complexity of the Basic Reproduction Number (R0). Emerg Infect Dis 2019; 25: 1-4; https://doi.org/10.3201/eid2501.171901

Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance 2020; 25: 2000058; https://doi.org/10.2807/1560-7917.ES.2020.25.4.2000058

World Health Organization, WHO Director-General’s Remarks at the Media Briefing on COVID-19 on 11 March 2020. (2020). Available at https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (last accessed April 2020)

World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report 71. (2020). Available at https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200331-sitrep-71-covid-19.pdf?sfvrsn=4360e92b_4 (last accessed April 2020)

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDCWeekly. Available at http://www.ourphn.org.au/wp-content/uploads/20200225-Article-COVID-19.pdf (last accessed April 2020)

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA Published online February 24, 2020; https://doi.org/10.1001/jama.2020.2648

Global Surveillance for human infection with coronavirus disease (COVID-19) Interim guidance 27 February 2020 (2020). Available at https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov) (last accessed April 2020)

Li Q, Med M, Guan X, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199-207; https://doi.org/10.1056/NEJMoa2001316

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506; https://doi.org/10.1016/S0140-6736(20)30183-5

Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-33; https://doi.org/10.1056/NEJMoa2001017

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13; https://doi.org/10.1016/S0140-6736(20)30211-7

Jiang F, Deng L, Zhang L, et al. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med (2020); Published 4 March 2020; https://doi.org/10.1007/s11606-020-05762-w

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance 13 March 2020 (2020). Available at https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected (last accessed April 2020)

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection, Clinical Chemistry and Laboratory Medicine (CCLM) (published online ahead of print 3 March 2020), 20200198; https://doi.org/10.1515/cclm-2020-0198

Han R, Huang L, Jiang H, et al. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. AJR Am J Roentgenol 2020: 1-6; https://doi.org/10.2214/AJR.20.22961

Peng QY, Wang XT, Zhang LN; Chinese Critical Care Ultrasound Study Group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med Published 12 March 2020; https://doi.org/10.1007/s00134-020-05996-6

World Health Organization. (2020). Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization 2020. Available at https://apps.who.int/iris/handle/10665/331329 (last accessed April 2020)

World Health Organization. (2020). Infection prevention and control during healthcare when COVID-19 is suspected. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control (last accessed April 2020)

Downloads

Published

2020-04-03

Issue

Vol. 14 No. 1 (2020)

Section

Brief report

License

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)